BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukocyte
,
Laryngoscope
,
Acetaminophen
,
rs2476601
,
LEP
,
Angiogenesis
,
Diabetes mellitus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
exportin-1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
T Lymphocyte (regulatory) of peripheral blood
Hematopoietic stem cell of bone marrow
Natural killer cell of peripheral blood
Endometrium
Peritoneum
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Injury of eye region
Infection by Nippostrongylus
Hepatocellular dysplasia
Disease due to Arenavirus
Interstitial lung disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
1-(5-(2-thenyloxy)-1H-indol-3-yl)propan-2-amine
Colistin
lactofen
zaleplon
N-methylolacrylamide
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Ptger4
PATL1
DSE
CRYAB
lmd
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Identifying novel inhibitors targeting Exportin-1 for the potential treatment of COVID-19.
The nuclear export protein XPO1 provides a peptide ligand for natural killer cells.
Clinicopathological and prognostic significance of XPO1 in solid tumors: meta-analysis and TCGA anal…
Electrophile Determines Cellular Phenotypes among XPO1-Targeting Small Molecules.
Coptisine inhibits the malignancy of bladder carcinoma cells and regulates XPO1 expression.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase 1 Trial of a Novel XPO1 Inhibitor in Patients With Advanced Solid Tumors
Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Ca…
Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma
Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957)
Elotuzumab, Selinexor, and Dexamethasone for Relapsed Refractory Multiple Myeloma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ